Primary Care Physicians’ Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs

被引：0
作者：
E. Jennifer Edelman
Brent A. Moore
Sarah K. Calabrese
Gail Berkenblit
Chinazo Cunningham
Viraj Patel
Karran Phillips
Jeanette M. Tetrault
Minesh Shah
David A. Fiellin
Oni Blackstock
机构：
[1] Yale University School of Medicine,Center for Interdisciplinary Research on AIDS
[2] Yale University School of Public Health,undefined
[3] Yale University School of Public Health,undefined
[4] George Washington University,undefined
[5] Johns Hopkins University,undefined
[6] Montefiore and Albert Einstein College of Medicine,undefined
[7] NIDA-IRP,undefined
[8] NIH,undefined
[9] University of Illinois – Chicago,undefined
来源：
AIDS and Behavior | 2017年 / 21卷
关键词：
HIV prevention; Pre-exposure prophylaxis; Attitude of health personnel; Substance abuse; Prevención del VIH; Profilaxis previa a la exposición; Actitud del personal de salud; Abuso de sustancias;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Pre-exposure prophylaxis for HIV (PrEP) is recommended for people who inject drugs (PWID). Despite their central role in disease prevention, willingness to prescribe PrEP to PWID among primary care physicians (PCPs) is largely understudied. We conducted an online survey (April–May 2015) of members of a society for academic general internists regarding PrEP. Among 250 respondents, 74% (n = 185) of PCPs reported high willingness to prescribe PrEP to PWID. PCPs were more likely to report high willingness to prescribe PrEP to all other HIV risk groups (p’s < 0.03 for all pair comparisons). Compared with PCPs delivering care to more HIV-infected clinic patients, PCPs delivering care to fewer HIV-infected patients were more likely to report low willingness to prescribe PrEP to PWID (Odds Ratio [95% CI] = 6.38 [1.48–27.47]). PCP and practice characteristics were not otherwise associated with low willingness to prescribe PrEP to PWID. Interventions to improve PCPs’ willingness to prescribe PrEP to PWID are needed.
引用
收藏
页码：1025 / 1033
页数：8
相关论文
共 149 条
  • [1] Mathers BM(2008)Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review Lancet. 372 1733-1745
  • [2] Degenhardt L(2010)Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions Curr HIV/AIDS Rep. 7 99-106
  • [3] Phillips B(2014)Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness Int J Drug Policy 25 34-52
  • [4] Wiessing L(2011)Oral substitution treatment of injecting opioid users for prevention of HIV infection Cochrane Database Syst Rev. 30 815-826
  • [5] Hickman M(2016)HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks AIDS 17 18899-2090
  • [6] Strathdee SA(2014)HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research J Int AIDS Soc. 381 2083-824
  • [7] Strathdee SA(2013)Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial Lancet 29 819-500
  • [8] Stockman JK(2015)The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs AIDS. 16 485-1295
  • [9] MacArthur GJ(2004)Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users AIDS Care. 64 1291-219
  • [10] van Velzen E(2015)Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition—United States, 2015 MMWR Morb Mortal Wkly Rep 7 210-1700
12345678910